Terragen Holdings Full Year 2025 Earnings: AU$0.008 loss per share (vs AU$0.009 loss in FY 2024)

Advertisement

Terragen Holdings (ASX:TGH) Full Year 2025 Results

Key Financial Results

  • Revenue: AU$1.80m (down 16% from FY 2024).
  • Net loss: AU$3.72m (loss widened by 24% from FY 2024).
  • AU$0.008 loss per share.
earnings-and-revenue-history
ASX:TGH Earnings and Revenue History August 28th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Terragen Holdings shares are down 19% from a week ago.

Risk Analysis

What about risks? Every company has them, and we've spotted 4 warning signs for Terragen Holdings (of which 3 are concerning!) you should know about.

Valuation is complex, but we're here to simplify it.

Discover if Terragen Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About ASX:TGH

Terragen Holdings

Engages in the research, development, and commercialization of biological products for the agriculture sector in Australia and New Zealand.

Excellent balance sheet with low risk.

Advertisement

Weekly Picks

LO
Lou_Basenese
GANX logo
Lou_Basenese on Gain Therapeutics ·

The Market Is Sleeping on This Parkinson's Biotech - And I Think That's a Mistake

Fair Value:US$7.671.8% undervalued
17 users have followed this narrative
0 users have commented on this narrative
16 users have liked this narrative
KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.234.8% undervalued
44 users have followed this narrative
1 users have commented on this narrative
17 users have liked this narrative
TE
BUSER logo
TechMegaTrends on Bambuser ·

Bambuser is today the only listed company in Europe that simultaneously possesses an 85% gross margin, proprietary AI infrastructure for the

Fair Value:SEK 238.2685.8% undervalued
31 users have followed this narrative
0 users have commented on this narrative
13 users have liked this narrative
HE
HedgeY
CSTM logo
HedgeY on Constellium ·

Constellium jet another cyclical aluminum processor, or a mispriced aluminum platform?

Fair Value:US$3412.8% undervalued
4 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative

Updated Narratives

JI
BFBIO logo
jibran5237 on BF Biosciences ·

BFBIO is a long-duration growth platform

Fair Value:PK₨554.0472.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
FA
ADNEX logo
FA_Trader on Adnex Group Berhad ·

Adnex: A straightforward fit-out business with real earnings, order book support, and room to grow

Fair Value:RM 0.4540.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AL
alegget
FWON.K logo
alegget on Formula One Group ·

Formula One: "Away we go" or "driving to survive"?

Fair Value:US$53.3769.5% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TR
tripledub
MSFT logo
tripledub on Microsoft ·

Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.

Fair Value:US$3954.1% overvalued
47 users have followed this narrative
3 users have commented on this narrative
42 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$587.3130.0% undervalued
1362 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative
RO
Robbo
TSLA logo
Robbo on Tesla ·

The academically fascinating Tesla

Fair Value:US$301.2k% overvalued
38 users have followed this narrative
11 users have commented on this narrative
32 users have liked this narrative